nature medicine semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial Semaglutide targets MASH molecular pathways

For many people, excess weight is not simply a matter of willpower

Semaglutide has demonstrated some efficacy in treating alcohol addiction

Yesmany versions are FDA-approved specifically for weight loss in non-diabetic patients.

Additionally, oxidative stress, lipid peroxidation, and iron homeostasis imbalance exacerbate the aggregation of Htt with other proteins, leading to increased glutamate excitotoxicity, disrupted mitochondrial function, altered autophagy mechanisms, impaired axonal transport, and ultimately neuronal degeneration, thereby causing the motor, cognitive, and behavioral symptoms of HD (Reichert et al., 2020)

However, patients may experience sensations of feeling cold for reasons indirectly related to the medication's effects, particularly its impact on body weight and composition

Pregnancy and breastfeeding - GLP-1 medications are not recommended during pregnancy or breastfeeding